¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"spinal muscular atrophy, type III"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
¿µ¹® spinal nerve ÇÑ±Û Ã´¼ö½Å°æ
¼³¸í   
  Ã´¼öÀÇ ¾Õ»Ô¿¡¼­ Ãâ¹ßÇϴ ¿îµ¿½Å°æ°ú µÞ»ÔÀ¸·Î µé¾î¿À´Â °¨°¢½Å°æÀÌ ÇÕÃļ­ Çü¼ºµÇ´Â ½Å°æÀ¸·Î¼­ ÃÑ 31½ÖÀÌ Á¸ÀçÇÔ. ¸ñ»À½Å°æÀÌ 8½Ö, ÀÚµî»À½Å°æÀÌ 12½Ö, Ç㸮»ÀÀÇ ½Å°æÀÌ 5½Ö, ¾ûÄ¡»ÀÀÇ 6½ÖÀ» ÀÌ·ë.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • muscular hyperesthesia
    ±Ù(À°)°¨°¢°ú¹Î(Áõ)
  • muscular hypotonia
    ±Ù(À°)±äÀåÀúÇÏ
  • muscular neurotization
    ±ÙÀ°½Å°æÀç»ý
  • muscular paralysis
    ±Ù(À°)¸¶ºñ
  • muscular process
    ±ÙÀ°µ¹±â
  • muscular reflex
    ±Ù(À°)¹Ý»ç
  • muscular stiffness
    ±Ù(À°)°æÁ÷, ±Ù(À°)°­Á÷
  • muscular strabismus
    ±ÙÀ°¼º»ç½Ã
  • muscular strain
    1. ±Ù(À°)°úµµ±äÀå 2. ±ÙÀ°¿°ÁÂ
  • muscular tissue
    ±Ù(À°)Á¶Á÷
  • muscular triangle
    ±Ù(À°)»ï°¢
  • oculopharyngeal muscular dystrophy
    ´«ÀεαÙ(À°)µð½ºÆ®·ÎÇÇ
  • progressive muscular dystrophy
    ÁøÇà±Ù(À°)µð½ºÆ®·ÎÇÇ
  • atrophy
    À§Ãà(Áõ)
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cellular type
    ¼¼Æ÷Çü
  • lepromatous type
    ³ªÁ¾Çü
  • scirrhous type
    °æÈ­Çü
  • spinal cord
    ô¼ö
  • spinal disease
    ô¼öº´
  • spinal ganglion
    ô¼ö½Å°æÀý
  • spinal headache
    ôÃ߸¶ÃëµÎÅë
  • spinal cord injury
    ô¼ö¼Õ»ó
  • spinal nerve
    ô¼ö½Å°æ
  • spinal reflex
    ô¼ö¹Ý»ç
  • spinal
    ô¼ö-, ôÃß-
  • spinal segment
    ô¼öºÐÀý
  • spinal tap
    ôÃßõÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heavy muscular work
    Áß±ÙÀ°ÀÛ¾÷
  • muscular hyperesthesia
    ±ÙÀ°°¨°¢°ú¹Î
  • muscular hypotonia
    ±ÙÀ°±äÀåÀúÇÏ
  • idiopathic muscular spasm
    Ư¹ß±ÙÀ°¿¬Ãà
  • muscular neurotization
    ±ÙÀ°³»½Å°æÀç»ý
  • muscular paralysis
    ±ÙÀ°¸¶ºñ
  • muscular process
    ±ÙÀ°µ¹±â
  • muscular reflex
    (¢¡stretch reflex) »¸Ä§¹Ý»ç, ½ÅÀå¹Ý»ç
  • muscular stiffness
    ±ÙÀ°°æÁ÷, ±ÙÀ°°­Á÷
  • muscular strabismus
    ±ÙÀ°»ç½Ã
  • muscular strain
    ±ÙÀ°°úµµ±äÀå
  • muscular tissue
    ±ÙÀ°Á¶Á÷
  • muscular ventricular septum
    ±ÙÀ°½É½Ç»çÀ̸·, ±ÙÀ°½É½ÇÁß°Ý
  • atrophy
    ˤ̈
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arsenazo III dye
    ¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
  • artery,medium muscular
    ±ÙÀ°¼º Áßµ¿¸Æ(ÐÉë¿àõñéÔÑØæ)
  • group III fiber
    Á¦¥²¤Çí·A.
  • group III fiber
    Á¦¥²±º¼¶À¯(ÏØàéë«).
  • heavy (muscular) work
    Áß(±Ù)ÀÛ¾÷(̡˻ËöËâ).
  • idiopathic muscular spasm
    Ư¹ß¼º ±Ù¿¬Ãà(÷åÛ¡àõÐÉÕýõê).
  • idiopathic muscular spasm
    Ư¹ß¼º ±Ù¿¬Ãà(Ư¹ß¼º±Ù·ÃÃà).
  • infantile muscular spasm
    ¿µ¾Æ±ÙÀ°¿¬Ãà.
  • peroneal muscular dystrophy
    ºñ°ñ±ÙÀ§ÃàÁõ(Þ¡ÍéÐÆê×õêñø)
  • platelet factor III
    Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
  • procollagen III peptide
    ÇÁ·ÎÄݶó°Õ III ÆéƼµå
  • pseudohypertrophy,in muscular dystrophy
    ±ÙÀÌ¿µ¾ç(Áõ)ÀÇ ¡­(ÐÉì¶ç½å×(ñø)¡­)
  • pseudounipolar(bipolar III) disorder
    °¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
  • SSP= spasmodic spinal paralysis
    °­Á÷¼º ô¼ö¸¶ºñ.
  • anterior spinal artery
    ¾Õô¼öµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • muscular atrophy
    ±ÙÀ§Ãà(¡­ê×õê)
  • muscular atrophy
    ±ÙÀ§Ãà(ÐÉê×õê).
  • myelopathic muscular atrophy
    ô¼öº´Áõ¼º ±ÙÀ§Ãà.
  • myopathic progressive muscular atrophy
    ±Ùº´Áõ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõÐÉê×õêñø).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõ ÐÉê×õêñø)
  • neurogenic muscular atrophy
    ½Å°æ¼º ±ÙÀ§Ãà(Áõ).
  • neurospinal muscular atrophy
    ½Å°æÃ´¼ö¼º±ÙÀ§Ãà(~ô±âÐàõÐÉê×õê).
  • peroneal muscular atrophy
    ºñ°ñ±Ù À§ÃàÁõ(ÝëÍéÐÉê×õêñø).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • spinobulbar muscular atrophy
  • muscular type of artery
    ±ÙÀ°Çüµ¿¸Æ
  • muscular type of lymphatic vessel
    ±ÙÀ°Çü¸²ÇÁ°ü
  • muscular type of vein
    ±ÙÀ°ÇüÁ¤¸Æ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Muscular triangle
    ±ÙÀ°»ï°¢
    [¿¾ ¿ë¾î] ±Ù»ï°¢
  • Muscular venule
    ±ÙÀ°¼¼Á¤¸Æ
    [¿¾ ¿ë¾î] ±Ù¼ÒÁ¤¸Æ
  • Muscular substance
    ±ÙÀ°Áú
    [¿¾ ¿ë¾î] ±ÙÁú
  • Muscular coat
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Muscular layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Muscular coat [Myometrium]
    ±ÙÀ°Ãþ [ÀڱñÙÀ°Ãþ]
    [¿¾ ¿ë¾î] ±ÙÃþ(ÀڱñÙÃþ)
  • Muscular branch to thyrohyoideus
    ¹æÆÐ¸ñ»Ô±Ù°¡Áö
    [¿¾ ¿ë¾î] °©»ó¼³°ñ±ÙÁö
  • Longitudinal muscular wall
    ¼¼·Î±ÙÀ°º®
    [¿¾ ¿ë¾î] Á¾ÁÖ±Ù°û
  • Cardiac muscular tissue
    ½ÉÀå±ÙÀ°Á¶Á÷
    [¿¾ ¿ë¾î] ½É±ÙÁ¶Á÷
  • Muscular fasciae
    ¾È±¸±Ù¸·
    [¿¾ ¿ë¾î] ¾È±Ù±Ù¸·
  • Medial muscular branch
    ¾ÈÂʱÙÀ°°¡Áö
    [¿¾ ¿ë¾î] ³»Ãø±ÙÁö
  • MUSCULAR COAT OF PHARYNX
    ÀεαÙÀ°Ãþ
    [¿¾ ¿ë¾î] ÀεαÙÃþ
  • Muscular layer of pharynx
    ÀεαÙÀ°Ãþ
    [¿¾ ¿ë¾î] ÀεαÙ
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷(Á¦1Çü»ç±¸¼¼Æ÷)
  • Regular type
    ±ÔÄ¢Çü
    [¿¾ ¿ë¾î] ±ÔĢġ¹Ð°áÇÕÁ¶Á÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • plaque-type mutant
    ÇöóÅ©Çü(û¡) º¯ÀÌü(ܨì¶ô÷)
  • transaminase-type mechanism
    Æ®¶õ½º¾Æ¹Ì³×À̽ºÇü (úþ) ±âÀü(Ѧï®)
  • type A hepatitis
    AÇü(úþ) °£¿°(ÊÜæú)
  • type A RNA virus
    AÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type B hepatitis
    BÇü(úþ) °£¿°(ÊÜæú)
  • type B RNA virus
    BÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type C virus
    CÇü(úþ) ¹ÙÀÌ·¯½º
  • type C RNA virus
    CÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type I error
    IÇü(úþ) ¿ÀÂ÷(è¦ó¬)
  • type II error
    IIÇü(úþ) ¿ÀÂ÷(è¦ó¬)
  • type I immunoglobulin
    IÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type II immunoglobulin
    IIÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type K immunoglobulin
    KÇü(úþ) ¸é¿ª(Øóæ¹) ±Û·ÎºÒ¸°
  • type L immunoglobulin
    LÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type-specific antigen
    ÇüƯÀÌ Ç׿ø(úþ÷åì¶ù÷ê«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • optic atrophy
    ½Ã½Å°æÀ§Ãà
  • optic nerve atrophy
    ½Ã½Å°æÀ§Ãà
  • senile atrophy
    ³ë³â(³ëÀÎ)¼ºÀ§Ãà
  • thenar atrophy
    ¹«Áö±¸À§Ãà
  • anterior spinal artery
    Àüô¼öµ¿¸Æ
  • progressive spinal amyotrophy
    ÁøÇ༺ô¼ö¼º±ÙÀ§ÃàÁõ
  • spinal
    ô¼öÀÇ, ôÃßÀÇ
  • spinal artery
    ô¼öµ¿¸Æ
  • spinal canal
    ôÃß°ü
  • spinal cord
    ô¼ö
  • spinal dysraphism
    ôÃßÈıù̺À(Áõ)
  • spinal fluid
    ô¼ö¾×
  • spinal muscle
    °¡½Ã±Ù, ±Ø±Ù
  • spinal tap
    ô¼öõÀÚ
  • spinal tract
    ô¼ö·Î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSMA chronic spinal muscular atrophy
FSHSMA facioscapulohumeral spinal muscular atrophy
PSMA proximal spinal muscular atrophy
SBMA spinal bulbar muscular atrophy
SMA sequential multiple analysis or analyzer; sequential multichannel autoanalyzer; simultaneous multich...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HTLV-III Human T-cell leukaemia virus type III
HTLV-III Human T-lymphotropic virus type III
FN III fibronectin type III
HTLV-III/LAV human T cell lymphotropic virus type III/lymphadenopathy associated virus
HTLV-III/LAV human T lymphotrophic virus type III/lymphadenopathy-associated virus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • facioscapulohumeral muscular dystrophy
    ¾È¸é °ß°© »ó¿Ï±Ù ÀÌ¿µ¾çÁõ
  • mixed muscular vascular headache
    ±Ù¸Æ°ü¼º È¥ÇÕ µÎÅë, È¥ÇÕµÈ ±Ù-Ç÷°ü¼º µÎÅë, È¥ÇÕ¼º ±ÙÀ° Ç÷°ü µÎÅë, È¥ÇÕÇü ±Ù¸Æ°ü¼º µÎÅë
  • muscular activity
    ±ÙÀ° Ȱµ¿, ±Ù Ȱ¼ºµµ
  • muscular ankylosis
    ±Ù¼º °­Á÷, ±Ù¼º °­Á÷Áõ
  • muscular asthenia
    ±Ù ¹«·ÂÁõ
  • muscular branch
    ±ÙÀ° °¡Áö, ±ÙÁö
  • muscular coat myometrium
    ±ÙÀ°Ãþ Àڱà ±ÙÀ°Ãþ
  • muscular contracture
    ±Ù °æÃà, ±Ù ¼öÃà, ±Ù ¼öÃàÁõ
    1. ±ÙÀ° ±æÀÌÀÇ °¨¼Ò·Î ÀÎÇØ ¼öµ¿Àû ±Ù ½ÅÀå¿¡ ´ëÇÑ ÀúÇ×ÀÇ Áõ°¡°¡ °è¼Ó Áö¼ÓµÇ´Â »óÅÂ. 2. ±ÙÀ°ÀÌ ¼¶À¯¼º, ¹ÝÈ缺ÀÌ µÇ°í ÃæºÐÈ÷ ´Ã¾î³ªÁö ¾Ê°Ô µÈ »óÅÂÀÌ°í ´ëÇ¥ÀûÀÎ °ÍÀÌ ´ëÅð»çµÎ±Ù ±Ù ¼öÃàÁõ°ú »ó°¢±Ù ±Ù ¼öÃàÁõÀÌ´Ù. ¸ðµÎ ±¹¼Ò¿¡ ´ëÇÑ ¹Ýº¹µÇ´Â ±ÙÀ° Áֻ簡 ¿øÀÎÀÌ µÇ´Â °æ¿ì°¡ ¸¹´Ù. ±Ù ¼öÃàÀÌ ½ÉÇÏ°í ±â´ÉÀå¾Ö°¡ ÀÎÁ¤µÇ´Â °æ¿ì¿¡´Â ¼ö¼ú·Î ¹ÝÈçÀ» ÀýÁ¦Çϰųª ±Ù ¿¬Àå¼úÀ» ÇàÇÑ´Ù. 3. ±ÙÀ°ÀÌ Àڱؿ¡ ¹ÝÀÀÇÏ¿© ¼öÃàÇÏ´Â Çö»ó. Á¼Àº ¶æÀ¸·Î´Â ôÃßµ¿¹°ÀÇ °ñ°Ý±Ù¿¡¼­ º¼ ¼ö ÀÖ´Â ¹Ù¿Í °°Àº ÀüÆÄ¼º Ȱµ¿ ÀüÀ§¿¡ ±âÀÎÇÏ´Â ¼öÃàÀ» °¡¸®Å°¸ç, ´ÜÀÏ È°µ¿ ÀüÀ§¿¡ ÀÇÇÑ ´Ü ¼öÃà°ú ¹Ýº¹ Ȱµ¿ ÀüÀ§¿¡ ÀÇÇÑ °­ ¼öÃàÀÌ ÀÖ´Ù. Ȱµ¿ ÀüÀ§¸¦ ÅëÇÏÁö ¾ÊÀº ±Ù ¼öÃàÀº ´ëºÎºÐ ºñÀüÆÄ¼ºÀÎ Å»ºÐ±ØÀ¸·Î ÀϾ´Âµ¥, Å»ºÐ±ØÀÌ ±ÙÀ°ÀÇ ±¹ºÎ¿¡ ÇÑÁ¤µÇ°í ¶ÇÇÑ Àϰú¼ºÀÎ °æ¿ì¿¡´Â ±¹¼Ò ¼öÃàÀ̶ó Çϰí, Å»ºÐ±ØÀÌ ±ÙÀ°ÀÇ ÀüÀå¿¡ °ÉÄ¡°í ¶ÇÇÑ Áö¼ÓÀûÀÎ °æ¿ì¿¡´Â ±¸ÃàÀ̶ó ÇÑ´Ù. ¹Î¹«´Ì±Ù µî¿¡¼­ º¼ ¼ö ÀÖ´Â Áö¼ÓÀû ¼öÃàÀ» ÀϹÝÀûÀ¸·Î Åä³Ê½º
  • muscular disorder
    ±ÙÀ° Àå¾Ö
  • muscular endurance
    ±Ù Áö±¸·Â
    ±ÙÀÌ ÀÏÁ¤ÇÑ ¼Óµµ¿Í °­µµ¸¦ Áö´Ñ ¿îµ¿À» Áö¼ÓÀûÀ¸·Î ÇÒ ¼ö ÀÖ´Â ´É·Â. ±Ù Áö±¸·ÂÀº ±Ù Ç÷·ù·®°ú ±ÙÀÇ »ê¼Ò ¼·Ãë·®°ú Ä¿´Ù¶õ °ü°è¸¦ Áö´Ï°í ÀÖ´Ù. ÀÌ¿¡ ´ëÇØ¼­ ±Ù·ÂÀº ½Ã°£À̶ó´Â ¿ä¼Ò°¡ Æ÷ÇÔµÇÁö ¾ÊÀº ¼ø°£ÀûÀÎ Àå·ÂÀ» ¸»ÇÏ°í ´Ü¸éÀûÀ̳ª Ȱµ¿ÇÏ´Â ±Ù ¼¶À¯ÀÇ ¼ö¿Í °ü°è°¡ ÀÖ´Ù.
  • muscular flaccidity
    ±Ù ÀÌ¿Ï, ±Ù À̿ϼº
  • muscular hernia
    ±Ù Çã´Ï¾Æ
    ±ÙÀÌ ¼Õ»óµÈ ±Ù¸·ÀÇ ÀçÁø Æ´¿¡¼­ Å»ÃâÇØ ÇÇÇÏ¿¡ ´ê´Â »óŸ¦ ¸»ÇÑ´Ù. ±ÙÀ» ½ÅÀüÇÑ »óÅ¿¡¼­´Â ¿ëÀÌÇÏ°Ô È¯³³ÇÒ ¼ö ÀÖ°í °¡º­¿î °ÍÀº ¹æÄ¡Çصµ ÁöÀåÀº ¾ø´Âµ¥ °íµµÀÇ °ÍÀº ±Ù¸·ÀÇ ÀçÁø Æ´À» º¸ÇÕÇÏ°í Æó¼âÇÑ´Ù.
  • muscular hypertrophy
    ±ÙÀ° ºñ´ëÁõ, ±ÙÀ° ºñ´ë, ±Ù ºñ´ë
    ±Ù ºñ´ë´Â ±Ù ¼¶À¯ÀÇ Å©±âÀÇ Áõ°¡¸¦ ÀǹÌÇÑ´Ù. Áö¹æ ħÀ±, Á¾¾ç, ¿°Áõ¼º º´º¯¿¡ µû¸¥ ¿Ü°ß»ó ºñ´ë¸¦ °¡¼º ºñ´ë¶ó°í ÇÏ°í »ç½Ç»óÀÇ ºñ´ë¿Í ±¸º°ÇÑ´Ù. °Ç°­ÇÑ ±ÙÀ°µµ Àå±â¿¡ °ÉÄ£ °úÀ× ÀÛ¾÷À¸·Î ÀÎÇØ ºñ´ë¸¦ ÀÏÀ¸Å²´Ù. ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõÀÇ °æ¿ì ºñÀå±ÙÀÇ ºñ´ë°¡ Á¾Á¾ ù Áõ»óÀÌ µÈ´Ù. ¼±Ãµ¼º ±Ù ±äÀåÁõ¿¡¼­µµ ±Ù ºñ´ë¸¦ º¸°Ô µÈ´Ù. ±Ù ºñ´ë¿¡´Â ³²¼º È£¸£¸ó µîÀÇ ³»ºÐºñ ÀÎÀÚµµ Áß¿äÇÑ ¿ªÇÒÀ» Áö´Ñ´Ù.
  • muscular paralysis
    ±Ù ¸¶ºñ
  • muscular reflex
    ±Ù ¹Ý»ç, ±ÙÀ° ¹Ý»ç
    ±ÙÀ° ½ÅÀüÀ¸·Î ÀϾ´Â ¹Ý»ç ¿îµ¿.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
ischemic muscular atrophy See: Volkmann's contracture.
(05 Mar 2000)
juvenile muscular atrophy Slowly progressive proximal muscular weakness and wasting, beginning in childhood, caused by degeneration of motor neurons in the anterior horns of the spinal cord; onset usually between 2 and 17 years of age; usually autosomal recessive inheritance.
Synonym: juvenile muscular atrophy, Kugelberg-Welander disease, Wohlfart-Kugelberg-Welander disease.
(05 Mar 2000)
glycogen storage disease type III <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system).
The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent.
Inheritance: autosomal recessive
(12 Dec 1998)
protoporphyrinogen type III The immediate precursor of protoporphyrin III in haem biosynthesis; elevated in cases of variegate porphyria.
(05 Mar 2000)
protoporphyrinogen type III oxidase A mitochondrial enzyme that uses O2 to convert protoporphyrinogen type III to protoporphyrin type III in haem biosynthesis; a deficiency of this enzyme is associated with variegate porphyria.
(05 Mar 2000)
protoporphyrin type III 2,7,12,18-Tetramethyl-3,8-divinylporphin-13,17dipropionic acid;the principal protoporphyrin found in nature (one of 15 possible isomers), characterised by the presence of 4 methyl groups, 2 vinyl groups, and 2 propionic acid side chains; a porphyrin derivative that, with iron, forms the haem of haemoglobin and the prosthetic groups of myoglobin, catalase, cytochromes, etc.
(05 Mar 2000)
hyperlipoproteinaemia type III A rather uncommon form of familial hyperlipaemia characterised by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-vldl and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal vldl.
(12 Dec 1998)
deoxyribonucleases, type III site-specific <enzyme> Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as atpases. They exist as complexes with modification methylases of similar specificity.
The systems recognise specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.5
(12 Dec 1998)
type III acrocephalosyndactyly An autosomal dominant syndrome with variable expression of brachycephaly, maxillary hypoplasia, prominent ear crus, syndactyly, facial asymmetry, shallow orbits, telecanthus, and nasal septal deviation; may show mental retardation.
Synonym: Saethre-Chotzen syndrome.
(05 Mar 2000)
type III collagen Collagen characteristic of reticular fibres.
(05 Mar 2000)
type III familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by increased plasma levels of LDL, beta-lipoproteins, pre-beta-lipoproteins, cholesterol, phospholipids, and triglycerides; hypertriglyceridemia induced by a high carbohydrate diet, and glucose tolerance is abnormal; frequent eruptive xanthomas and atheromatosis, particularly coronary artery disease; biochemical defect lies in apolipoproteins; there are many varieties.
Synonym: carbohydrate-induced hyperlipaemia, dysbetalipoproteinaemia, familial hyperbetalipoproteinaemia and hyperprebetalipoproteinaemia, familial hypercholesterolaemia with hyperlipaemia.
(05 Mar 2000)
type III hyperlipoproteinaemia <biochemistry> An inherited disorder (gene defect) where both cholesterol and triglycerides are elevated in the same patient. This condition accelerates the effects of atherosclerosis and thus increases the risk of cardiovascular disease. Conditions such as hypothyroidism, obesity and diabetes enhances this risk.
Origin: Gr. Haima = blood
(27 Sep 1997)
type III hypersensitivity reaction An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
type III mucopolysaccharidosis <syndrome> An error of the mucopolysaccharide metabolism, with excretion of large amounts of heparan sulfate in the urine and severe mental retardation with hepatomegaly; skeleton may be normal or may present mild changes similar to those in Hurler's syndrome; several different types (A, B, C, and D) have been identified according to the enzyme deficiency; autosomal recessive inheritance.
Synonym: type III mucopolysaccharidosis.
(05 Mar 2000)
Becker type muscular dystrophy A muscular dystrophy that has many of the clinical features of Duchenne muscular dystrophy e.g., symmetrical involvement of first the pelvicrural muscles and then the pectoral girdle and proximal upper extremity muscles; pseudohypertrophy, especially of the calf muscles but with a much later age of onset (35-45 years), and more benign course. X-linked inheritance.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cold type
    ÄݵåŸÀÌÇÁ(»çÁø.½ÄÀÚµî ȰÀÚ ÁÖÁ¶¸¦ ÇÏÁö ¾Ê´Â ½ÄÀÚ)
  • cold type system
    Äݵå ŸÀÌÇÁ ½Ã½ºÅÛ(³³È°ÀÚ³ª ¿­À» »ç¿ëÇÏÁö ¾Ê°í Çʸ§À» ÁÖü·ÎÇÑ »ç½ÄÈ­¿¡ ÀÇÇÑ Àμ⠰øÁ¤
  • condensed type
    °¡´Ã°í ±ä ȰÀÚ
  • display type
    Ç¥Á¦;±¤°í¿ëÀÇ ´ëÇü ȰÀÚ
  • foundry type
    ¼öÁ¶ÆÇ ȰÀÚ
  • ideal type
    ÀÌ»óÇü
  • italic type
    (ÀÎ)ÀÌÅÚ¸¯Ã¼;»çü
  • moon type
    (¸ÍÀοëÀÇ)¹®½Ä¼±ÀÚ
  • repulsive(-type) maglev
    ¹Ý¹ß½Ä Àڱ⠺λó(Â÷ü¸¦ ¶ß°ÔÇϱâ À§ÇØ ÀüÀÚ¼®ÀÇ ¹Ý¹ß·ÂÀ» ÀÌ¿ë)
  • type
    Çü;À¯Çü;¾ç½Ä;ÀüÇü;°ßº»;Ç¥;ȰÀÚ;Ç÷¾×Çü;in ~ ȰÀڷΠ§(Â¥¼­);set ~ Á¶ÆÇÇÏ´Ù
  • type
    ŸÀÌÇÁ¶óÀÌÅÍ·Î Âï´Ù;(Ç÷¾×)ÇüÀ» °Ë»çÇÏ´Ù;»ó¡ÇÏ´Ù;...ÀÇ ÀüÇüÀÌ µÇ´Ù
  • type cast
    (±ØÁß Àι°ÀÇ ½ÅÀå,¸ñ¼Ò¸® µûÀ§¿¡ ¸Â´Â) ¹è¿ì¸¦ ¹è¿ªÇÏ´Ù
  • type founder
    ȰÀÚ ÁÖÁ¶°ø(¾÷ÀÚ)
  • type metal
    ȰÀÚ ÇÕ±Ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á